SynthesisEuropean archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery2026
Prevalence of Central Compartment Atopic Disease (CCAD): a systematic review and meta-analysis.
Synthesis in European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCentral compartment atopic disease (CCAD) is a subtype of chronic rhinosinusitis characterized by polypoid edema and mucosal changes localized to the central sinonasal compartment, particularly the middle turbinate, superior turbinate, and posterosuperior nasal septum, in association with inhalant allergy. Despite increasing recognition, its epidemiologic burden remains poorly defined.
methodsAll studies reporting the proportion of CCAD among CRS were extracted from OVID Medline, Scopus, and EBSCO CINAHL. A review of title and abstracts was done independently by seven reviewers. The quality of the studies was assessed using the Newcastle-Ottawa scale. Meta-analysis was performed using R v.4.1.1, using the 'meta', 'tidyverse', and 'metafor' packages (version 4.19-0).
resultsSeven studies from the United States and Asia were included in the study. The pooled proportion of CCAD was 23.0% (95% CI 15.0%-33.0%). Subgroup analyses suggested variability by region being higher in Asia and sex, showing higher prevalence in males; however, these analyses were exploratory in nature and intended to identify potential sources of heterogeneity rather than establish definitive subgroup differences.
conclusionCCAD represents a substantial proportion of chronic rhinosinusitis with nasal polyps (CRSwNP) cases globally, though estimates are limited by marked heterogeneity and inconsistent diagnostic criteria. Standardized case definitions and wider geographic surveillance are essential to better characterize the global burden and phenotypic diversity of CCAD.
Indexed as
Identifiers
42215785What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.